PHB2 and breast cancer: To further validate the KPNA-mediated E2-dependent nuclear translocation of endogenous PHB2 in breast cancer cells, we examined the knockdown effect of each KPNA via siRNA treatment on the subcellular distribution of endogenous PHB2 in MCF-7 cells after BIG3 knockdown followed by E2 treatment.